Navigation Links
The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results
Date:8/4/2009

SFAS No. 123R and in employer taxes associated with the exercise of employee stock options. The Company has recorded all these expenses in the same line items as other compensation paid to the relevant categories of employees. THE ADVISORY BOARD COMPANY CONSOLIDATED BALANCE SHEETS (In thousands) June 30, March 31, 2009 2009 ---- ---- (unaudited) ASSETS Current assets: Cash and cash equivalents $14,528 $23,746 Marketable securities 11,022 8,385 Membership fees receivable, net 124,552 116,739 Prepaid expenses and other current assets 4,727 5,113 Deferred income taxes, net 3,239 3,083 ----- ----- Total current assets 158,068 157,066 Property and equipment, net 32,724 34,156 Intangible assets, net 4,456 4,463 Goodwill 24,908 24,563 Deferred incentive compensation and other charges 27,183 26,737 Deferred income taxes, net of current portion 7,673 7,555 Other non-current assets 5,000 - Marketable securities 57,697 61,718 ------ ------ Total assets $
'/>"/>
SOURCE The Advisory Board Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board
2. Allergists Urge Asthmatics to Get Swine and Seasonal Flu Shots Following CDC Vaccine Advisory Committee Recommendations
3. Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board
4. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results
5. WellPoint State Sponsored Business President Appointed Advisory Board Member of the HIMSS Board of Directors
6. VA Advisory Committee on Women Veterans Visits Dallas
7. The Beryl Companies Welcomes Three New Members to its Executive Advisory Council
8. Pennsylvania Patient Safety Authority Releases June Advisory
9. Renowned Medical Tourism Industry Expert and Author Josef D. Woodman Joins Satori World Medical's Strategic Advisory Board
10. Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
11. Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDCs Advisory Committee on Immunization Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 Beverly Hills Cosmetic ... health and beauty products to be sold at the offices ... in Beverly Hills, and worldwide through an online store ... to fill the gap between dental care and beauty with ... beautiful and youthful,” says Dr. Glosman. , Dr. Glosman’s ...
(Date:5/5/2015)... New Jersey (PRWEB) May 05, 2015 ... has maintained its strong and secure credit rating of ... of Horizon BCBSNJ’s financials last week, the Wall Street ... adequacy” and “leading market position” in determining the rating ... of mind is one of our top priorities, so ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... ) filed on behalf of men who ... their use of prescription testosterone replacement therapies ... multidistrict litigation underway in U.S. District Court, ... documents dated May 1st, defendants AbbVie, Inc., ...
(Date:5/5/2015)... CT (PRWEB) May 05, 2015 Sunny skies ... Cove Island Park as nearly 400 runners and walkers participated ... Run,” raising nearly $35,000. , The 5K and ... awareness about Lyme disease and to raise funds for tick-borne ... event created by the recent merger of Lyme ...
(Date:5/5/2015)... May 05, 2015 In a April 25, ... The Herald-Times , the Missouri State Highway Patrol (MSHP) announced ... production or use for the second year in a row. ... the FBI, reported 1,469 incidents in 2014 alone, around 15% ... around 2% of the US Population calls Indiana home, according ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2
... form of childhood disease, study says , , WEDNESDAY, Jan. ... identified a subtype of T-lymphoblastic leukemia (T-ALL) in children ... , Approximately 20 percent of children with T-ALL ... others with the disease, and doctors had been unable ...
... a provider of enterprise case management solutions that streamline ... a new Lagan Human Services Call Center solution ... in North America. The new solution is an ... range of functions depending on the programs administered, from ...
... of Wisdom(TM) as Worldwide Symbol for Cervical Cancer ... Month in the United States, a coalition of ... and others is partnering with their European counterparts ... cervical cancer worldwide. The Pearl of Wisdom ...
... Program ReviewsSEATTLE, Jan. 14 MetaStar, Wisconsin,s ... guidelines and software from Milliman Care Guidelines ... medical care reviews throughout the state. ... Care Guidelines (R) suite, MetaStar now uses ...
... Heavily in Promotion to Capture Share in Mature ... ResourcesWALTHAM, Mass., Jan. 14 Decision Resources, one ... focusing on pharmaceutical and healthcare issues, finds that ... in Europe) will propel Roche to sixth position ...
... market test, Uno Chicago Grill(R) will offer its new, ... dining chain to offer a gluten-free pizza and received ... disease, which affects approximately one percent of the population. ... during the northeastern market test prompted the company to ...
Cached Medicine News:Health News:Hard-to-Treat Leukemia Cell Subtype Identified 2Health News:Lagan Unveils Human Services Call Center Solution for North America 2Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 2Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 3Health News:U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer 4Health News:Milliman Care Guidelines(R) Replaces Multiple Guideline Sets for Wisconsin QIO 2Health News:Milliman Care Guidelines(R) Replaces Multiple Guideline Sets for Wisconsin QIO 3Health News:Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012 2Health News:Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012 3Health News:Uno Chicago Grill(R) Rolls Out Gluten-Free Pizza Nationally 2
(Date:5/5/2015)...  Trovagene, Inc. (NASDAQ:  TROV), a developer of ... for the three months ended March 31, 2015. ... presented favorable clinical results at ASCO GI, AACR, ... Precision Cancer Monitoring platform,s ability to detect and ... cancers," said Antonius Schuh, Ph.D., chief executive officer ...
(Date:5/5/2015)... NEW YORK , May 5, 2015  IBM ... it is collaborating with more than a dozen leading ... identify and personalize treatment options for their patients. The ... cognitive capabilities to reduce from weeks to minutes the ... profile and gather relevant information from medical literature to ...
(Date:5/5/2015)... , May 5, 2015 ... at $94.9 million in 2014, and is estimated to ... of 7.8% from 2014 to 2019. Browse ... Device Market for an analysis of industry trends and ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3
... NEW YORK, Sept. 6, 2011 ... market research report is available ... Licensing Strategies of Large ... Pipelines and the Patent Cliff ...
... Global regenerative medicine company, Mesoblast Limited, (ASX: ... from the European Medicines Agency (EMA) to begin ... Europe for its lead cardiovascular product Revascor(TM) in ... heart failure after a major heart attack. Revascor(TM) ...
Cached Medicine Technology:Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 2Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 3Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 4Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 5Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 6Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 7Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 8Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 9Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 10Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 11Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 12Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 13Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 14Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 15Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity 16Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks 2Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks 3Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: